ONE-POT SYNTHESIS OF CARBAMODITHIOATE
1729
1
3
3
(45%): H NMR: δ = 0.89 (3H, t, J 7.3, Me), 1.46 (3H, d, J 6.0, Me), 2.13–2.15 (2H,
m, CH2), 3.24–3.26 (2H, m, CH2), 4.28–4.30 (1H, m, CH), 5.06–5.08 (1H, m, CH). 13C
NMR: δ = 11.5 (Me), 16.9 (Me), 25.7 (CH2), 36,8 (CH2), 43.9 (CH), 56.7 (CH-N), 175.5
(C O), 176.1 (C O), 205.1 (C S).
Tetrahydro-2,5-dioxofuran-3-yl n-butylcarbamodithioate (3d). Pale yellow
crystals; yield: 0.41g (83%); mp 139–140◦C. IR (KBr) (νmax/cm−1): 3444, 2605, 1733,
1703, 1437, 1361, 1284, 1194. EI-MS: 247 (M+, 7), 201 (12), 191 (15), 133 (18), 114
(100), 57 (25), 43 (18); Anal. Calcd. for C9H13NO3S2 (247.2): C, 43.71; H, 5.30; N,
1
3
5.67%. Found: C, 43.01; H, 5.42; N, 5.59%. H NMR: δ = 0.95 (3H, t, J 7.2, Me),
1.36–1.38 (2H, m, CH2), 1.61–1.63 (2H, m, CH2), 3.07 (1H, dd, 2J 18.0, 3J 8.7, CH), 3.3
(1H, dd, 2J 18.0, 3J 3.9, CH), 4.00 (1H, t, 3J 7.6, CH2), 4.42 (1H, dd, 3J 8.7, 3J 3.9, CH),
10.98 (1H, br s, NH). 13C NMR: δ = 14.0 (Me), 20.4 (CH2), 29.0 (CH2), 36.9 (CH2), 45.1
(CH), 45.6 (CH2), 175.9 (C O), 176.0 (C O), 200.7 (C S).
Tetrahydro-2,5-dioxofuran-3-yl cyclohexylcarbamodithioate (3e). Pale
yellow crystals; yield: 0.50 g (92%); mp 186–187◦C. IR (KBr) (νmax/cm−1): 3462, 2532,
1743, 1701, 1465, 1396, 1284, 1199. EI-MS: 273 (M+, 9), 192 (100), 174 (36), 140 (17),
81 (17), 55 (34), 41 (25); Anal. Calcd. for C11H15NO3S2 (273.3): C, 48.34; H, 5.53; N,
1
5.13%. Found: C, 48.01; H, 5.65; N, 5.23%. H NMR: δ = 1.20–2.40 (10 H, m, 5 CH2),
2
3
2
3
3
3.06 (1H, dd, J 18.0, J 8.3, CH), 3.23 (1H, dd, J 18.0, J 3.9, CH), 4.25 (1H, dd, J
8.3, 3J 3.9, CH), 4.8 (1H, br s, NH). 13C NMR: δ = 25.4 (CH2), 26.3 (CH2), 26.4 (CH2),
27.7 (CH2), 27.9 (CH2), 36.6 (CH2), 43.7 (CH), 58.8 (CHN), 176.2 (C O), 176.9 (C O),
201.7 (C S).
Tetrahydro-2,5-dioxofuran-3-yl benzylcarbamodithioate (2f). Yellow crys-
tals; yield: 0.49 g (92%); mp 139–140◦C. IR (KBr) (νmax/cm−1): 3404, 2560, 1706, 1688,
1425, 1349, 1174, 1107. EI- MS: 281 (M+, 11), 235 (7), 149 (21), 148 (70), 91 (100), 65
(18), 45 (8). Anal. Calcd. for C12H11NO3S2 (281.3): C, 51.23; H, 3.94; N, 4.98%. Found:
C, 51.4; H, 4.11; N, 5.09%. 1H NMR: δ = 3.06 (1H, dd, 2J 18, 3J 8.0, CH), 3.32 (1H, dd,
2J 18.0, 3J 3.9, CH), 3.65 (1H, bs, NH), 4.46 (1H, dd, 3J 8.0, 3J 3.9, CH), 5.20 (2 H, ABq,
νꢀAB = 22 Hz, 2JAB 14.2, CH2), 7.30–7.42 (5H, m, CH-arom). 13C NMR: δ 36.6 (CH2),
45.7 (CH), 48.2 (CH2N), 128.6 (CH), 129.0 (2CH), 129.3 (2CH), 134.9(C), 174.4 (C O),
175.8 (C O), 200.4 (C S).
Tetrahydro-2,5-dioxofuran-3-yl 4-chlorobenzylcarbamodithioate (3g).
Pale yellow crystals; yield: 0.38 g (60%); mp 139–140◦C. IR (KBr) (νmax/cm−1): 3481,
2598, 1742, 1721, 1492, 1346, 1203, 1089. EI-MS: 317 (M+2, 6), 315 (M+, 20), 269 (8),
187 (11), 182 (68), 125 (100), 91 (10); Anal. Calcd. for C12H10NO3S2Cl (315.7): C, 45.65;
H, 3.51; N, 4.44%. Found: C, 45.23; H, 3.60; N, 4.52%. 1H NMR: δ 3.10 (1H, dd, 2J 18,
3J 8.2, CH), 3.27 (1H, dd, 2J 18.0, 3J 3.9, CH), 4.44 (1H, dd, 3J 8.2, 3J 3.9, CH), 5.15 (2H,
2
3
3
ABq, νꢀAB = 7 Hz, JAB 10.1, CH2) 7.28 (d, J 8.0, 2CH), 7.38 (2H, d, J 8.0, 2CH),
10.17 (1H, br s, NH). 13C NMR: δ = 36.5 (CH2), 45.7 (CH), 47.5 (CH2N), 129.1 (2CH),
130.9 (2CH), 133.3 (C), 134.5 (C), 175.7 (C O), 175.8 (C O), 200.2 (C S).
Tetrahydro-2,5-dioxofuran-3-yl 4-methylbenzylcarbamodithioate (3h).
Pale yellow crystals; yield: 0.52 g (89%); mp 172–174◦C. IR (KBr) (νmax/cm−1): 3481,
2590, 1747, 1720, 1492, 1346, 1272, 1196. EI-MS: 295 (M+, 6), 249 (7), 162 (48), 105
(100), 91 (13); Anal. Calcd. for C13H13NO3S2 (295.3): C, 52.87; H, 4.44; N, 4.74%.
1
2
Found: C, 52.95; H, 4.29; N, 4.87%. H NMR: δ = 2.33 (3 H, s, Me), 3.04 (1 H, dd, J
18.0, J 9.0, CH), 3.32 (1 H, dd, J 18.0, J 3.6, CH), 4.45 (1 H, dd, J 9.0, 3J 3.6, CH),
3
2
3
3
5.15 (2 H, ABq, νꢀAB = 11 Hz, JAB = 14.0, CH2), 7.12 (2 H, d, 3J 7.8, 2 CH), 7.32 (2 H,